Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1997 May;6(5):1009-15.
doi: 10.1002/pro.5560060506.

Three-dimensional structures of glycolate oxidase with bound active-site inhibitors

Affiliations
Comparative Study

Three-dimensional structures of glycolate oxidase with bound active-site inhibitors

K Stenberg et al. Protein Sci. 1997 May.

Abstract

A key step in plant photorespiration, the oxidation of glycolate to glyoxylate, is carried out by the peroxisomal flavoprotein glycolate oxidase (EC 1.1.3.15). The three-dimensional structure of this alpha/beta barrel protein has been refined to 2 A resolution (Lindqvist Y. 1989. J Mol Biol 209:151-166). FMN dependent glycolate oxidase is a member of the family of alpha-hydroxy acid oxidases. Here we describe the crystallization and structure determination of two inhibitor complexes of the enzyme, TKP (3-Decyl-2,5-dioxo-4-hydroxy-3-pyrroline) and TACA (4-Carboxy-5-(1-pentyl)hexylsulfanyl-1,2,3-triazole). The structure of the TACA complex has been refined to 2.6 A resolution and the TKP complex, solved with molecular replacement, to 2.2 A resolution. The Rfree for the TACA and TKP complexes are 24.2 and 25.1%, respectively. The overall structures are very similar to the unliganded holoenzyme, but a closer examination of the active site reveals differences in the positioning of the flavin isoalloxazine ring and a displaced flexible loop in the TKP complex. The two inhibitors differ in binding mode and hydrophobic interactions, and these differences are reflected by the very different Ki values for the inhibitors, 16 nM for TACA and 4.8 microM for TKP. Implications of the structures of these enzyme-inhibitor complexes for the model for substrate binding and catalysis proposed from the holo-enzyme structure are discussed.

PubMed Disclaimer

References

    1. J Biol Chem. 1985 Sep 15;260(20):11115-22 - PubMed
    1. Protein Expr Purif. 1996 Nov;8(3):295-8 - PubMed
    1. J Biol Chem. 1989 Feb 25;264(6):3624-8 - PubMed
    1. Eur J Biochem. 1995 Mar 1;228(2):408-16 - PubMed
    1. Pharmacol Res. 1994 Oct-Nov;30(3):281-8 - PubMed

Publication types